Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
25C-NBOH
JWH-018
Experience:337mg DMT fumarate - A Day With DMT
4-AcO-DMT
ALD-52
Allylescaline
2C-D
5-MeO-DiBF
25D-NBOMe
PRO-LAD
Phenylpiracetam
Experience:3g mimosa / 3g syrian rue - Connecting with my body
1B-LSD
Experience:BK-2C-B - Various experiences
ETH-LAD
Experience:120mg - Garden of The Gods
25B-NBOH
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:25mg 3-MeO-PCP - Enhanced film experience
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
4-HO-DPT
2C-E
4-FA
5-MeO-DiPT
DiPT
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
2C-B-FLY
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
3-MeO-PCE
5-MeO-DALT
Piracetam
AL-LAD
MDA
PARGY-LAD
25C-NBOMe
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
LSD
EPT
Experience:1000 Morning Glory seeds - Rediscovering the Self
Methallylescaline
Psilocybin mushrooms
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
DOI
LSZ
Pramiracetam
6-APDB
Experience:2 tabs DOB - My DOB Nightmare
2C-T-2
Experience:3-MeO-PCP - Extreme psychosis
2C-H
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
DET
THJ-2201
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Tree.jpgJapanese Garden by Anonymous
3-MMC
25B-NBOMe
LSM-775
2C-B
4-HO-DET
4-HO-MiPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Psilocin
MiPT
Proscaline
LSA
4-HO-DiPT
DMT
Experience:300µg LSD - Togetherness and the Silent Dusk
Omberacetam
4-AcO-DiPT
4-AcO-MET
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
DPT
Experience:250mg DXM - DXM Itch and Trip Report
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
2C-T-7
6-APB
Βk-2C-B
4-AcO-MiPT
Ibogaine
MiPLA
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Efavirenz
1P-ETH-LAD
4-HO-EPT
5-MeO-MiPT
4-AcO-DET
Experience:4x 200ug tabs - You do not need to understand
2C-C
2C-P
TMA-2
Chameleon.jpgChameleon by Anonymous.
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Experience:300µg AL-LAD - Don't worry, because you're everyone!
25I-NBOH
MDAI
Enhancement of colour rose.jpgRose by Chelsea Morgan
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Phenethylamine (compound)
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:1mg 25c-NBOMe - Experiment in my room
Pregabalin
Mescaline
GABAergic hallucinogens
2C-T-21
Bromo-DragonFLY
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
25N-NBOMe
Paradise island by Xanny.jpgParadise island by Subsentience
Experience:800 seeds LSA - My First Trip Ever
Bufotenin
Ayahuasca
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
TMA-6
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
MDEA
Chur City in Switzerland.jpgChur, Switzerland by Naps284
DOC
2C-I
Amanita muscaria
Escaline
MPT
DOB
Selective serotonin reuptake inhibitor
1P-LSD
MET
Oxiracetam
THJ-018
Experience:4-HO-MiPT / A care free psychedelic getaway
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
4-HO-MET
MDMA
4-HO-MPT
ΑMT
25I-NBOMe
5F-PB-22
JWH-073
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
3C-E
5-Hydroxytryptophan
Memantine
Experience:40mg - Brothermind and the Forest's Hand
Aniracetam

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.